Merus N.V.

TGF-BETA-RII BINDING PROTEINS

#2 | 2025-07-17

US20250230579A1

GENERATION OF BINDING MOLECULES

#3 | 2024-12-26

US20240425595A1

NOVEL PD-1 BINDING DOMAINS

#4 | 2024-12-26

US20240425594A1

NOVEL PD-1 BINDING DOMAINS

#5 | 2024-08-08 ✅ Patent 12,503,509 granted on 2025-12-23

US20240262912A1

CLEC12AXCD3 BISPECIFIC ANTIBODIES AND METHODS FOR THE TREATMENT OF DISEASE

#6 | 2024-07-04

US20240218070A1

FAP BINDING DOMAINS AND BISPECIFIC BINDING MOIETIES THAT BIND FAP AND TGF-ßRII

#7 | 2024-06-06 ✅ Patent 12,247,078 granted on 2025-03-11

US20240182587A1

ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene

#8 | 2024-05-16

US20240158532A1

ANTIBODY THAT BINDS ERBB-2 AND ERBB-3

#9 | 2024-05-16

US20240158531A1

ANTIBODY THAT BINDS ERBB-2 AND ERBB-3

#10 | 2024-05-16

US20240156072A1

ANTIBODY PRODUCING NON-HUMAN ANIMALS

#11 | 2024-01-25

US20240023527A1

ANTIBODY PRODUCING NON-HUMAN ANIMALS

#12 | 2023-12-21

US20230406932A1

ANTIBODIES THAT MODULATE A BIOLOGICAL ACTIVITY EXPRESSED BY A CELL

#13 | 2023-10-26 ✅ Patent 11,926,859 granted on 2024-03-12

US20230340556A1

Methods and means for the production of Ig-like molecules

#14 | 2023-08-10

US20230250190A1

BINDING DOMAINS AGAINST CANCER-ASSOCIATED MUC1

#15 | 2023-08-03 ✅ Patent 12,139,548 granted on 2024-11-12

US20230242669A1

Antibody that binds ErbB-2 and ErbB-3

#16 | 2023-06-22

US20230192866A1

TREATMENT OF CANCERS WITH AN ANTIBODY THAT BINDS LGR5 AND EGFR

#17 | 2023-05-25 ✅ Patent 12,291,798 granted on 2025-05-06

US20230160105A1

Generation of binding molecules

#18 | 2023-05-25

US20230159645A1

MULTISPECIFIC BINDING MOIETIES COMPRISING PD-1 AND TGF-BRII BINDING DOMAINS

#19 | 2023-02-02 ✅ Patent 11,993,654 granted on 2024-05-28

US20230036061A1

PD-1 binding domains

#20 | 2022-12-01

US20220380440A1

TRUNCATED MULTIVALENT MULTIMERS

#21 | 2022-11-24

US20220372166A1

MEANS AND METHODS FOR TREATING SUBJECTS WITH HER2 AND HER3 POSITIVE CANCER

#22 | 2022-11-10 ✅ Patent 12,460,002 granted on 2025-11-04

US20220356251A1

CD3 BINDING MOLECULES

#23 | 2022-11-03

US20220348683A1

ANTIBODY THAT BINDS ERBB-2 AND ERBB-3

#24 | 2022-04-28

US20220127376A1

COMBINATIONS OF BINDING MOIETIES THAT BIND EGFR, HER2 AND HER3

#25 | 2022-04-28

US20220127375A1

PRODUCING COMPOSITIONS COMPRISING TWO OR MORE ANTIBODIES

#26 | 2022-03-10

US20220073649A1

MIXED BINDING DOMAINS

#27 | 2022-01-13 ✅ Patent 11,873,338 granted on 2024-01-16

US20220010013A1

CLEC12AxCD3 bispecific antibodies and methods for the treatment of disease

#28 | 2021-05-27 ✅ Patent 11,820,825 granted on 2023-11-21

US20210155698A1

Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumor

#29 | 2021-03-11 ✅ Patent 12,123,043 granted on 2024-10-22

US20210071222A1

Methods and means for the production of Ig-like molecules

#30 | 2021-02-25 ✅ Patent 12,195,551 granted on 2025-01-14

US20210054096A1

Combination of an ErbB-2/ErbB-3 bispecific antibody with endocrine therapy for breast cancer

#31 | 2020-12-10

US20200384084A1

USE OF BISPECIFIC ANTIBODY AND IL-15 FOR COMBINATION THERAPY

#32 | 2020-10-15 ✅ Patent 11,667,714 granted on 2023-06-06

US20200325227A1

Binding molecules that modulate a biological activity expressed by a cell

#33 | 2020-10-08

US20200319181A1

ANTIBODY PRODUCING NON-HUMAN ANIMALS

#34 | 2020-08-06 ✅ Patent 11,408,095 granted on 2022-08-09

US20200247908A1

Generation of binding molecules

#35 | 2020-07-09 ✅ Patent 11,732,043 granted on 2023-08-22

US20200216540A1

Antibodies that modulate a biological activity expressed by a cell

#36 | 2020-01-16 ✅ Patent 10,752,929 granted on 2020-08-25

US20200017897A1

Methods and means for the production of ig-like molecules

#37 | 2020-01-16 ✅ Patent 11,685,786 granted on 2023-06-27

US20200017595A1

Binding molecules that bind CD137 and PD-L1

#38 | 2019-11-21 ✅ Patent 11,952,424 granted on 2024-04-09

US20190352401A1

Multivalent antibody

#39 | 2019-11-21 ✅ Patent 12,060,418 granted on 2024-08-13

US20190352393A1

Bispecific IgG antibodies as T cell engagers

#40 | 2019-07-11 ✅ Patent 11,739,148 granted on 2023-08-29

US20190211100A1

Human CD3 binding antibody

#41 | 2018-11-01 ✅ Patent 11,939,394 granted on 2024-03-26

US20180312604A1

Binding molecules that inhibit cancer growth

#42 | 2018-08-23 ✅ Patent 10,266,593 granted on 2019-04-23

US20180237523A1

Human CD3 binding antibody

#43 | 2018-06-28 ✅ Patent 10,647,781 granted on 2020-05-12

US20180179300A1

Generation of binding molecules

#44 | 2018-05-24

US20180142006A1

ANTIBODY PRODUCING NON-HUMAN ANIMALS

#45 | 2018-05-24

US20180142005A1

ANTIBODY PRODUCING NON-HUMAN ANIMALS

#46 | 2018-05-24 ✅ Patent 11,925,174 granted on 2024-03-12

US20180142004A1

Antibody producing non-human animals

#47 | 2018-05-24

US20180142003A1

ANTIBODY PRODUCING NON-HUMAN ANIMALS

#48 | 2018-05-24 ✅ Patent 11,785,924 granted on 2023-10-17

US20180142002A1

Antibody producing non-human animals

#49 | 2018-05-17 ✅ Patent 11,559,049 granted on 2023-01-24

US20180134770A1

Antibody producing non-human animals

#50 | 2018-04-26

US20180112247A1

RECOMBINANT PRODUCTION OF MIXTURES OF ANTIBODIES

#51 | 2018-04-05

US20180094289A1

RECOMBINANT PRODUCTION OF MIXTURES OF ANTIBODIES

#52 | 2018-02-01 ✅ Patent 11,237,165 granted on 2022-02-01

US20180031555A1

Antibody producing non-human animals

#53 | 2018-01-04

US20180002405A1

METHOD FOR SELECTING A SINGLE CELL EXPRESSING A HETEROGENEOUS COMBINATION OF ANTIBODIES

#54 | 2018-01-04 ✅ Patent 10,670,599 granted on 2020-06-02

US20180002404A1

Method for selecting a single cell expressing a heterogeneous combination of antibodies

#55 | 2017-12-28 ✅ Patent 10,329,596 granted on 2019-06-25

US20170369923A1

Methods and means for the production of Ig-like molecules

#56 | 2017-11-16 ✅ Patent 10,337,045 granted on 2019-07-02

US20170327860A1

Methods and means for the production of Ig-like molecules

#57 | 2017-03-02 ✅ Patent 10,844,127 granted on 2020-11-24

US20170058035A1

Antibodies that bind EGFR and ErbB3

#58 | 2017-02-09 ✅ Patent 11,279,770 granted on 2022-03-22

US20170037145A1

Antibody that binds ErbB-2 and ErbB-3

#59 | 2016-12-22 ✅ Patent 9,914,777 granted on 2018-03-13

US20160368988A1

Human CD3 binding antibody

#60 | 2016-11-03 ✅ Patent 10,934,571 granted on 2021-03-02

US20160319320A1

Recombinant production of mixtures of antibodies

#61 | 2016-08-18 ✅ Patent 10,605,808 granted on 2020-03-31

US20160238600A1

Antibody producing non-human animals

#62 | 2016-06-23 ✅ Patent 9,758,805 granted on 2017-09-12

US20160177364A1

Methods and means for the production of Ig-like molecules

#63 | 2016-05-12 ✅ Patent 9,908,946 granted on 2018-03-06

US20160130367A1

Generation of binding molecules

#64 | 2014-10-23 ✅ Patent 9,765,133 granted on 2017-09-19

US20140317766A1

Antibody producing non-human mammals

#65 | 2014-10-23 ✅ Patent 9,944,695 granted on 2018-04-17

US20140314755A1

Antibody producing non-human mammals

#66 | 2014-05-01 ✅ Patent 10,358,492 granted on 2019-07-23

US20140120096A1

Bispecific IgG antibodies as T cell engagers

#67 | 2013-06-06 ✅ Patent 9,951,124 granted on 2018-04-24

US20130145484A1

Antibody producing non-human mammals

#68 | 2012-07-12 ✅ Patent 9,738,701 granted on 2017-08-22

US20120177637A1

Method for selecting a single cell expressing a heterogeneous combination of antibodies

#69 | 2010-06-10 ✅ Patent 10,966,411 granted on 2021-04-06

US20100146647A1